The US Food and Drug Administration (FDA) is planning to regulate the use of the cannabis compound CBD in food and supplements after weighing the evidence on the compound's safety.
The FDA will decide whether regulating legal cannabis will require new agency rules or new legislation from Congress.
Cannabis products, excluding Epidiolex, are illegal at the federal level in the US, although some states allow their use.
According to Patrick Cournoyer, who heads the FDA office developing the agency's cannabis strategy, the FDA will ascertain if CBD can be safely eaten every day for a long period or during pregnancy amid concerns about future fertility.
.


SpaceX, Charter Communications Explore Mobile Partnership to Expand Starlink Wireless Service
South Korea’s KOSPI Plunges as Apple Price Hikes and OpenAI IPO Delay Shake AI Chip Stocks
S&P Affirms Brazil’s BB Credit Rating with Stable Outlook Amid Fiscal Challenges
Fortescue Faces Class Action Over Sexual Harassment Claims at Australian Mining Sites
Hantavirus Cruise Ship Outbreak Triggers Global Health Alert
HSBC Australia Faces A$35M Penalty Over Scam Protection Failures
Trump Team Rejects BBC Financial Data Request in $10B Lawsuit
DOJ Clears Paramount Skydance-Warner Bros. Discovery Merger Without Conditions
U.S. Supreme Court Allows Alabama’s Republican-Backed Congressional Map for 2026 Elections
Asian Markets Rally as Micron and Qualcomm AI Outlook Lifts Global Tech Stocks
Pedro Sanchez’s Wife Ordered to Stand Trial in Spain Corruption Case
US Appeals Court Keeps Trump’s 10% Global Tariff in Effect During Ongoing Legal Battle
Gold Prices Rise Above $4,000 as Inflation Data and Weaker Dollar Boost Demand
RFK Jr. Expands CDC Vaccine Advisory Panel's Scope Amid Legal Battles
Frank Stronach Found Guilty of Sexual Assault and Indecent Assault in Ontario Court
Trump Orders DOJ Investigation Into Exxon, Chevron Over High Gas Prices 



